Table 9.
Summary of Independent Samples t Test Between the 3 Groups.
| Parameter | Groups | Level of Significance of Differencea | |
|---|---|---|---|
| Average intensity | Diabetes–Normal | Significant | |
| Diabetes–Prediabetes | Significant | ||
| Normal–Prediabetes | Not significant | ||
| Average form coefficient | Diabetes–Normal | Highly significant | |
| Diabetes–Prediabetes | Significant | ||
| Normal-Prediabetes | Not significant | ||
| Average entropy | Diabetes–Normal | Highly significant | |
| Diabetes–Prediabetes | Highly significant | ||
| Normal–Prediabetes | Not significant | ||
| Average fractility | Diabetes–Normal | Significant | |
| Diabetes–Prediabetes | Highly significant | ||
| Normal-Pre diabetes | Not significant | ||
| Average liver | Diabetes–Normal | Highly significant | |
| Diabetes–Prediabetes | Not significant | ||
| Normal–Prediabetes | Not significant | ||
| Average immune organs | Diabetes–Normal | Very highly significant | |
| Diabetes–Prediabetes | Very highly significant | ||
| Normal–Prediabetes | Very highly significant | ||
| Average pancreas | Diabetes–Normal | Highly significant | |
| Diabetes-Prediabetes | Not significant | ||
| Normal–Prediabetes | Significant | ||
| Average coronary | Diabetes–Normal | Very highly significant | |
| Diabetes–Prediabetes | Highly significant | ||
| Normal–Prediabetes | Not significant | ||
| Average cerebral | Diabetes–Normal | Very highly significant | |
| Diabetes–Prediabetes | Significant | ||
| Normal–Prediabetes | Not significant | ||
| Average left kidney | Diabetes–Normal | Highly significant | |
| Diabetes–Prediabetes | Not significant | ||
| Normal–Prediabetes | Not significant | ||
| Average right kidney | Diabetes–Normal | Highly significant | |
| Diabetes–Prediabetes | Significant | ||
| Normal–Prediabetes | Not significant | ||
aP < .001 very highly significant; P < .01 highly significant; P < .05 significant.